홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1-Hydroxybenzotriazole → (Z)-4,4-difluoro-5-(2-{4-[2-(benzylamino)ethyl]piperidino)-2-oxoethylidene)-1-(4-methyl-2-phenylthiazole-5-carbonyl)-2,3,4,5-tetrahydro-1H-1-benzoazepine monohydrochloride

HRID 1251088
인쇄

반응식

HRID 1251088 반응식
[F:1][C:2]1([F:31])[CH2:3][CH2:4][N:5]([C:17]([C:19]2[S:23][C:22]([C:24]3[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=3)=[N:21][C:20]=2[CH3:30])=[O:18])[C:6]2[CH:16]=[CH:15][CH:14]=[CH:13][C:7]=2/[C:8]/1=[CH:9]/[C:10]([OH:12])=O.ON1C2C=CC=CC=2N=N1.[ClH:42].C(N=C=NCCCN(C)C)C.[CH2:54]([N:61](CC1C=CC=CC=1)[CH2:62][CH2:63][CH:64]1[CH2:69][CH2:68][NH:67][CH2:66][CH2:65]1)[C:55]1[CH:60]=[CH:59][CH:58]=[CH:57][CH:56]=1.C(=O)(O)[O-].[Na+]>O1CCCC1.C(N(CC)CC)C>[ClH:42].[F:1][C:2]1([F:31])[CH2:3][CH2:4][N:5]([C:17]([C:19]2[S:23][C:22]([C:24]3[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=3)=[N:21][C:20]=2[CH3:30])=[O:18])[C:6]2[CH:16]=[CH:15][CH:14]=[CH:13][C:7]=2/[C:8]/1=[CH:9]/[C:10]([N:67]1[CH2:66][CH2:65][CH:64]([CH2:63][CH2:62][NH:61][CH2:54][C:55]2[CH:56]=[CH:57][CH:58]=[CH:59][CH:60]=2)[CH2:69][CH2:68]1)=[O:12]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 5

HCID 757711-HydroxybenzotriazoleHCID 516892Sodium BicarbonateHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 66798731(Dibenzyl) [2-(4-piperidyl)ethyl]amineHCID 70160918(Z)-2-[4,4-difluoro-1-(4-methyl-2-phenylthiazole-5-carbonyl)-2,3,4,5-tetrahydro-1H-1-benzoazepin-5-ylidene]acetic acid

생성물 1

HCID 70161976
(Z)-4,4-difluoro-5-(2-{4-[2-(benzylamino)ethyl]piperidino)-2-oxoethylidene)-1-(4-methyl-2-phenylthiazole-5-carbonyl)-2,3,4,5-tetrahydro-1H-1-benzoazepine monohydrochloride
수율 3.5%

시약·촉매·용매 2

HCID 8028Tetrahydrofuran용매HCID 8471Triethylamine용매

실험 절차

To a solution of 260 mg of (Z)-[4,4-difluoro-1-(4-methyl-2-phenylthiazole-5-carbonyl)-2,3,4,5-tetrahydro-1H-1-benzoazepin-5-ylidene]acetic acid in 20 ml of tetrahydrofuran were added 118 mg of 1-hydroxybenzotriazole, 167 mg of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide monohydro-chloride, 600 mg of (dibenzyl) [2-(4-piperidyl)ethyl]amine and 310 μl of triethylamine, and the mixture was stirred at room temperature for 18 hours. To the reaction solution was added a saturated aqueous solution of sodium bicarbonate, and the mixture was extracted with ethyl acetate. The organic layer was washed with a saturated aqueous solution of NaCl and dried over magnesium sulfate, and the solvent was evaporated therefrom. The resulting residue (385 mg) was dissolved in 10 ml of dichloroethane, 64 μl of 1-chloroethyl chloroformate was added thereto, and the mixture was stirred with heating under refluxing for 4.5 hours. The solvent was evaporated, 10 ml of methanol was added to the residue, and the mixture was stirred with heating under refluxing for 4.5 hours. After cooling to room temperature, a saturated aqueous solution of sodium bicarbonate was added, and the mixture was extracted with ethyl acetate. The organic layer was washed with a saturated aqueous solution of NaCl and dried over anhydrous magnesium sulfate, and the solvent was evaporated therefrom. The residue was purified by silica gel column chromatography (eluting with chloroform-methanol). The resulting residue (22 mg) was dissolved in 0.1 ml of ethyl acetate, then 30 μl of a 4N HCl/ethyl acetate solution was added to the solution, and the mixture was stirred at room temperature. The solvent was evaporated therefrom, and the resulting solid was collected by filtration to give 14 mg of (Z)-4,4-difluoro-5-(2-{4-[2-(benzylamino)ethyl]piperidino)-2-oxoethylidene)-1-(4-methyl-2-phenylthiazole-5-carbonyl)-2,3,4,5-tetrahydro-1H-1-benzoazepine monohydrochloride as a colorless powder.

후처리

  1. extractionthe mixture was extracted with ethyl acetate
  2. washThe organic layer was washed with a saturated aqueous solution of NaCl
  3. dry with materialdried over magnesium sulfate
  4. customthe solvent was evaporated
  5. dissolutionThe resulting residue (385 mg) was dissolved in 10 ml of dichloroethane
  6. addition64 μl of 1-chloroethyl chloroformate was added
  7. stirringthe mixture was stirred
  8. temperaturewith heating
  9. temperatureunder refluxing for 4.5 hours
  10. customThe solvent was evaporated
  11. addition10 ml of methanol was added to the residue
  12. stirringthe mixture was stirred
  13. temperaturewith heating
  14. temperatureunder refluxing for 4.5 hours
  15. temperatureAfter cooling to room temperature
  16. additiona saturated aqueous solution of sodium bicarbonate was added
  17. extractionthe mixture was extracted with ethyl acetate
  18. washThe organic layer was washed with a saturated aqueous solution of NaCl
  19. dry with materialdried over anhydrous magnesium sulfate
  20. customthe solvent was evaporated
  21. customThe residue was purified by silica gel column chromatography (eluting with chloroform-methanol)
  22. dissolutionThe resulting residue (22 mg) was dissolved in 0.1 ml of ethyl acetate
  23. addition30 μl of a 4N HCl/ethyl acetate solution was added to the solution
  24. stirringthe mixture was stirred at room temperature
  25. customThe solvent was evaporated
  26. filtrationthe resulting solid was collected by filtration

출처 및 근거

ORD 기록
ord-40522718467748e88ebb4c31581e31c8
출처 데이터셋
uspto-grants-2002_01
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06340678B1

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트